Abstract

Nebivolol is a highly specific beta-blocking agent with vasodilating properties mediated by endothelial NO release. Aim of the study was to assess by a completely noninvasive approach the effects of Nebivolol on arterial blood pressure and left ventricular systolic function in patients with moderate to severe AH and normal LV mass and function at 2-D echo. Nine patients (4M, 5F) with a resting DP ≥95mmHg, were studied after adequate pharmacological washout and 14 days after oral treatment with Nebivolol 5 mg o.d. Arterial blood pressure was continuously monitored by Finapres and data stored on a computer. The 2D echo was continuously assessed by the apical 4 chamber approach and recorded on videotape; periodic markers on pressure were synchronized with the time display of the echocardiogram. Echo frames for measurement of end-systolic and end-diastolic volumes were selected at different values of arterial pressure during i.v. infusion of nitroprussiate. Relative changes in load-independent measurement of LV inotropism were obtained by comparing slope and intercept values of the end-systolic pressure/volume curves as well as the extrapolated areas under these curves for a constant volume range (0-50 ml) (P/V area). In addition, EF values before and after Nebivolol were compared for the same end-diastolic volume. Heart energy consumption was obtained by mean arterial pressure times cardiac output (CO). Results: significant changes in the clinostatic SBP and DBP after chronic treatment were reported in all pts (-14 and -21%, respectively), associated to a decrease in heart rate (-14%). In conclusion, Nebivolol exerted an hypotensive effect through a reduction of systemic vascular resistance and a mild reduction in CO. The negative inotropic effect, evident from the P/V areas, was counterbalanced by the reduction in SVR with maintained stroke volume. Nebivolol markedly decreased heart energy consumption per beat and per minute. (See Table)

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.